IDXX

IDEXX Laboratories Inc
NASDAQHEALTHCAREDIAGNOSTICS & RESEARCH

Key Statistics

Market Cap
$44.93B
P/E Ratio
40.97
EPS
$13.90
Beta
1.55
52W High
$769.98
52W Low
$518.55
50-Day MA
$555.77
200-Day MA
$621.46
Dividend Yield
Profit Margin
24.60%
Forward P/E
37.74
PEG Ratio
3.56

About IDEXX Laboratories Inc

IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$4.45B
Gross Profit (TTM)$2.76B
EBITDA$1.55B
Operating Margin31.80%
Return on Equity72.90%
Return on Assets26.50%
Revenue/Share (TTM)$55.57
Book Value$19.64
Price-to-Book28.20
Price-to-Sales (TTM)10.10
EV/Revenue10.07
EV/EBITDA28.76
Quarterly Earnings Growth (YoY)17.20%
Quarterly Revenue Growth (YoY)14.30%
Shares Outstanding$78.88M
Float$78.58M
% Insiders0.22%
% Institutions98.28%

Historical Volatility

HV 10-Day
32.76%
HV 20-Day
34.32%
HV 30-Day
35.63%
HV 60-Day
32.86%
HV Rank
73.0%

Volatility is currently contracting

Analyst Ratings

Consensus ($707.00 target)
4
Strong Buy
5
Buy
5
Hold
1
Strong Sell

Latest News

These 3 Water ETFs Could be Quiet Winners From Infrastructure Spending

Data centers receive sharp criticism for their high water usage, but the impact on the broader water industry and for investors is also about infrastructure bottlenecks, regulation, and emerging technologies, among other things. Utilities companies must navigate significant changes when hyperscalers enter their territory—in some cases, a new data center operator may immediately become one of the largest customers in the region.

MarketBeat7/14/2026Neutral
ALC vs. IDXX: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical - Instruments sector might want to consider either Alcon (ALC) or Idexx Laboratories (IDXX). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks Investment Research7/7/2026Positive
IDEXX Laboratories to Release 2026 Second Quarter Financial Results

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2026 second quarter financial results for Tuesday, August 4, 2026, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day. Individuals can access a live webcast of the conference call, transcript of prepared remarks, and the Q2 2026 Earnings Snapshot through a link on the IDEXX websi.

Business Wire7/1/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on IDXX and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 7/29/2026